Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial.
about
Rosuvastatin reduces the recurrence rate following catheter ablation for atrial fibrillation in patients with heart failure.Differences in Quality of Life Between Atrial Fibrillation Patients with Low Stroke Risk Treated With and Without Catheter Ablation.Atrial Fibrillation Symptoms and Sex, Race, and Psychological Distress: A Literature Review.Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF?Management of atrial fibrillation: when are invasive approaches useful?2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.Healthcare Utilization and Quality of Life Improvement after Ablation for Paroxysmal AF in Younger and Older Patients.2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.California study of Ablation (CAABL):early utilization after index hospitalization for non-valvular atrial fibrillation.Adjunctive Therapies for Catheter Ablation of Non-Paroxysmal Atrial Fibrillation.Temporal trends in atrial fibrillation recurrence rates after ablation between 2005 and 2014: a nationwide Danish cohort study.Patient-Reported Outcomes in Relation to Continuously Monitored Rhythm Before and During 2 Years After Atrial Fibrillation Ablation Using a Disease-Specific and a Generic Instrument.2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial designAtrial fibrillation
P2860
Q33597725-2883BB4F-5113-47BF-AE72-08387632901DQ36141824-FCBC79BA-8A77-4972-9D33-EFC5CC212E16Q38719244-591AC3D9-8CF7-4DA3-9E48-E8C5D42216FAQ38817707-4EC42C72-2B67-4686-A353-C4B3A74DE714Q38917093-C383FD28-7381-49F1-BECC-EC8A1464FC58Q45059153-7BA4373A-C68C-44CD-B3CF-5FF24F09ABE2Q46128944-728C7989-E5F2-4982-AC35-04B2CA1FEF28Q46658026-E7ABF452-F56B-44C7-8C9A-BFFBF06CD87AQ47098949-92D15C93-5FD3-484D-8F09-C0D518BD79F8Q47102409-496A110C-8125-46B8-A260-BAFE11118972Q47613589-25BB14C8-BED1-4BD6-A76C-3431696884C4Q50868122-02F12F6B-AFC2-47EB-97A5-4E97B74D2C5EQ55263071-5DF5767A-51F1-45CC-8E88-9AC1C24A1A7DQ58645594-88C8D7A9-EB9D-4752-B0C6-6A4871344F0F
P2860
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: results on health-related quality of life and symptom burden. The MANTRA-PAF trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Radiofrequency ablation as ini ...... burden. The MANTRA-PAF trial.
@en
type
label
Radiofrequency ablation as ini ...... burden. The MANTRA-PAF trial.
@en
prefLabel
Radiofrequency ablation as ini ...... burden. The MANTRA-PAF trial.
@en
P2093
P356
P1433
P1476
Radiofrequency ablation as ini ...... m burden. The MANTRA-PAF trial
@en
P2093
A Johannessen
G Hindricks
H Walfridsson
J Hartikainen
L S Mortensen
M Aronsson
O Kongstad
P304
P356
10.1093/EUROPACE/EUU342
P577
2015-01-06T00:00:00Z